Preanesthetic Medications: Classes, Actions, and Safe Handling

Why Preanesthetic Medications Matter

Before an animal receives a general anesthetic, veterinary professionals administer one or more preanesthetic ("premedication" or "premeds") drugs. These agents reduce anxiety and fear, lower the total dose of induction and maintenance anesthetics needed (a concept called balanced anesthesia), provide preemptive pain control, and make induction smoother and safer. Understanding each drug class—what it does, when to use it, and how to handle it safely—is a core competency for both veterinary assistants and credentialed veterinary technicians.

Anticholinergics

Anticholinergics such as atropine and glycopyrrolate block muscarinic acetylcholine receptors in the heart and glands. Their primary clinical use in anesthesia is to prevent or treat bradycardia (slow heart rate) and to reduce respiratory secretions that could obstruct the airway. Atropine crosses the blood-brain barrier and can cause excitement in some species; glycopyrrolate does not cross and is therefore preferred when central effects are unwanted. These are not controlled substances, but they require a valid veterinary order and must be stored and labeled according to practice protocol.

Key monitoring concern: anticholinergics increase heart rate, which raises myocardial oxygen demand. Monitor for tachycardia, especially in patients with pre-existing cardiac disease.

Phenothiazine Tranquilizers

Acepromazine is the most commonly used phenothiazine in veterinary medicine. It produces sedation and reduces anxiety by blocking dopamine receptors in the central nervous system. Acepromazine provides no analgesia on its own but potentiates the effects of other agents, allowing lower doses of those drugs. Important cautions include:

• It causes peripheral vasodilation and can produce significant hypotension, especially in debilitated, hypovolemic, or brachycephalic patients.
• There is no reversal agent for acepromazine.
• It lowers the seizure threshold and should be avoided in epileptic animals.
• It is not a controlled substance.

Alpha-2 Adrenergic Agonists

Dexmedetomidine and xylazine stimulate alpha-2 adrenergic receptors, producing dose-dependent sedation, muscle relaxation, and analgesia. They are among the most powerful sedatives used in veterinary practice and dramatically reduce the amount of induction agent needed.

Cardiovascular effects include an initial increase in blood pressure followed by bradycardia and reduced cardiac output. These drugs should be used cautiously or avoided in patients with cardiovascular, hepatic, or renal compromise.

A key advantage is reversibility: atipamezole reverses dexmedetomidine, and yohimbine can reverse xylazine. Reversal agents work quickly but may also reverse analgesia, so continued patient monitoring is essential after reversal.

Benzodiazepines

Diazepam and midazolam enhance the effect of the inhibitory neurotransmitter GABA, producing anxiolysis, muscle relaxation, and mild sedation. They provide no analgesia. Benzodiazepines have minimal cardiovascular depression, making them valuable in critical or geriatric patients. Midazolam is water-soluble and can be given intramuscularly; diazepam must be given intravenously or orally.

Flumazenil is the reversal agent for benzodiazepines. Both diazepam and midazolam are Schedule IV controlled substances under the federal Controlled Substances Act and require strict record-keeping.

Opioids

Opioids bind mu, kappa, and delta opioid receptors in the central and peripheral nervous systems to produce powerful analgesia and sedation. Common veterinary preanesthetic opioids include hydromorphone, morphine, butorphanol, and buprenorphine. They reduce the amount of inhalant anesthetic needed and are essential for preemptive pain management.

Potential adverse effects include respiratory depression, bradycardia, vomiting (especially morphine and hydromorphone), and, in cats, dysphoria at high doses. Naloxone reverses opioid effects rapidly, including analgesia, so use the minimum effective reversal dose and monitor closely.

Opioids are Schedule II through Schedule V controlled substances depending on the specific drug. Their handling is one of the most regulated activities in veterinary practice.

Safe Controlled-Substance Handling

Federal law (enforced by the Drug Enforcement Administration) requires that every veterinary practice registered with the DEA maintain a controlled-substance log for each drug. As a veterinary assistant or technician, you may be asked to assist with—or witness—these entries. A compliant log entry typically includes:

1. Date and time of administration

2. Patient name, species, and client name

3. Drug name, concentration, and total volume drawn

4. Volume administered and volume wasted

5. Signature of the administering veterinarian or licensed technician

6. Witness signature for any waste

Waste must be documented and witnessed immediately—never left until later. Controlled substances must be stored in a substantially constructed, locked cabinet accessible only to authorized personnel. Discrepancies between the log and the actual drug inventory must be reported promptly to the supervising veterinarian. Veterinary assistants must always operate within their scope of practice: you may handle and document these drugs as directed, but administration decisions and calculations must be confirmed with a licensed veterinarian or credentialed technician.

Key Safety Reminders

• Always verify the drug, dose, route, and patient before any premedication is given.
• Know the reversal agents and their locations in your practice.
• Report unexpected patient reactions (severe bradycardia, apnea, prolonged sedation) immediately.
• Never alter or backdate a controlled-substance log.